Blog

Jasmine Kamboj: Access to oncological drugs and clinical trials – US vs LMICs

Jasmine Kamboj/X

Mar 27, 2025, 13:57

Jasmine Kamboj: Access to oncological drugs and clinical trials – US vs LMICs

Jasmine Kamboj, Medical Oncologist and Hematologist at Mayo Clinic, shared a post on LinkedIn:

“Please join for the CPOEM Foundation and American Society of Clinical Oncology (ASCO) webinar on “Access to oncological drugs and clinical trials- US vs LMICs”.

3/28/25, 7:00 PM to 8:30 PM IST.

Stellar speakers like Robin Zon, Gilberto de lima Lopes Junior, Rachan Shetty KS, Dr. Vishwanath Sathyanarayanan, Jason Westin, Guru Sonpavde, Maryam Lustberg, Fredrick Chite Asirwa.

Thanks ASCO and CPOEM for this opportunity.”

Jasmine Kamboj: Access to oncological drugs and clinical trials - US vs LMICs

More posts featuring Jasmine Kamboj.

American Society of Clinical Oncology ASCO cancer clinical trials CPOEM Foundation Dr. Vishwanath Sathyanarayanan fight against cancer Fredrick Chite Asirwa Gilberto de Lima Lopes Junior Global fight against cancer Guru Sonpavde Jasmine Kamboj Jason Westin LMICs Maryam Lustberg Mayo Clinic MedOnc OncoDaily oncological drugs Oncology Rachan Shetty KS Robin Zon US

Cervical Cancer Screening: Who Needs a Pap Smear or HPV Test and When?

Clinical Trials in Cancer Care: What They Are, How to Join, and What to Expect

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More

Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology